Bright Peak Therapeutics

About:

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

Website: https://brightpeaktx.com

Top Investors: BlackRock, RA Capital Management, Alexandria Venture Investments, Fidelity, Invus

Description:

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases. The company's immunotherapies allow tissue and cell-specific targeting of the cytokine payload with the added potential for significantly enhanced efficacy.

Total Funding Amount:

$232M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Basel, Basel-Stadt, Switzerland

Founded Date:

2017-01-01

Founders:

Jeffrey Bode, Vijaya Pattabiraman

Number of Employees:

51-100

Last Funding Date:

2024-06-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai